These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 22245197

  • 1. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.
    Nichols RC, Huh SN, Prado KL, Yi BY, Sharma NK, Ho MW, Hoppe BS, Mendenhall NP, Li Z, Regine WF.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):158-63. PubMed ID: 22245197
    [Abstract] [Full Text] [Related]

  • 2. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
    Swanson EL, Indelicato DJ, Louis D, Flampouri S, Li Z, Morris CG, Paryani N, Slopsema R.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):1549-57. PubMed ID: 22270176
    [Abstract] [Full Text] [Related]

  • 3. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
    Milby AB, Both S, Ingram M, Lin LL.
    Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):e477-84. PubMed ID: 22177626
    [Abstract] [Full Text] [Related]

  • 4. Dosimetric comparison of doses to organs at risk using 3-D conformal radiotherapy versus intensity modulated radiotherapy in postoperative radiotherapy of periampullary cancers: implications for radiation dose escalation.
    Bahl A, Kapoor R, Tomar P, Singh OA, Gupta R, Sharma SC.
    JOP; 2013 Jan 10; 14(1):39-43. PubMed ID: 23306333
    [Abstract] [Full Text] [Related]

  • 5. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J, Abo-Madyan Y, Lohr F, Stieler F, Kriz J, Mueller RP, Wenz F, Eich HT.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):268-76. PubMed ID: 22079733
    [Abstract] [Full Text] [Related]

  • 6. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
    Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, Lynch J, Li Z, Mendenhall NP.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):260-7. PubMed ID: 22014950
    [Abstract] [Full Text] [Related]

  • 7. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM, Teo PM, Kam MK, Leung SF, Cheung KY, Chan AT.
    Med Dosim; 2007 May 01; 32(4):263-70. PubMed ID: 17980826
    [Abstract] [Full Text] [Related]

  • 8. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
    Boehling NS, Grosshans DR, Bluett JB, Palmer MT, Song X, Amos RA, Sahoo N, Meyer JJ, Mahajan A, Woo SY.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):643-52. PubMed ID: 21277111
    [Abstract] [Full Text] [Related]

  • 9. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
    Choi Y, Kim JK, Lee HS, Hur WJ, Chai GY, Kang KM.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):683-9. PubMed ID: 15927412
    [Abstract] [Full Text] [Related]

  • 10. Pancreatic cancer planning: Complex conformal vs modulated therapies.
    Chapman KL, Witek ME, Chen H, Showalter TN, Bar-Ad V, Harrison AS.
    Med Dosim; 2016 Nov 01; 41(2):100-4. PubMed ID: 26831922
    [Abstract] [Full Text] [Related]

  • 11. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP, Aghayere O, Kwah J, Yorke ED, Goodman KA.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):1580-6. PubMed ID: 22284687
    [Abstract] [Full Text] [Related]

  • 12. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours.
    Petersen JB, Lassen Y, Hansen AT, Muren LP, Grau C, Høyer M.
    Acta Oncol; 2011 Aug 01; 50(6):823-8. PubMed ID: 21767180
    [Abstract] [Full Text] [Related]

  • 13. Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for pancreatic malignancies.
    Ali AN, Dhabaan AH, Jarrio CS, Siddiqi AK, Landry JC.
    Med Dosim; 2012 Aug 01; 37(3):271-5. PubMed ID: 22189026
    [Abstract] [Full Text] [Related]

  • 14. A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma.
    Brown MW, Ning H, Arora B, Albert PS, Poggi M, Camphausen K, Citrin D.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):274-83. PubMed ID: 16618582
    [Abstract] [Full Text] [Related]

  • 15. Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer.
    Chung HT, Lee B, Park E, Lu JJ, Xia P.
    Int J Radiat Oncol Biol Phys; 2008 Jul 15; 71(4):1167-74. PubMed ID: 18234440
    [Abstract] [Full Text] [Related]

  • 16. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
    Cotter SE, Herrup DA, Friedmann A, Macdonald SM, Pieretti RV, Robinson G, Adams J, Tarbell NJ, Yock TI.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):1367-73. PubMed ID: 20934266
    [Abstract] [Full Text] [Related]

  • 17. Intensity-modulated radiotherapy for neoadjuvant treatment of gastric cancer.
    Knab B, Rash C, Farrey K, Jani AB.
    Med Dosim; 2006 Dec 01; 31(4):292-7. PubMed ID: 17134669
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma.
    van der Geld YG, van Triest B, Verbakel WF, van Sörnsen de Koste JR, Senan S, Slotman BJ, Lagerwaard FJ.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1215-20. PubMed ID: 18954715
    [Abstract] [Full Text] [Related]

  • 19. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.
    Nichols RC, Huh SN, Henderson RH, Mendenhall NP, Flampouri S, Li Z, D'Agostino HJ, Cury JD, Pham DC, Hoppe BS.
    Clin Lung Cancer; 2011 Jul 15; 12(4):252-7. PubMed ID: 21726825
    [Abstract] [Full Text] [Related]

  • 20. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J, Lang J, Wang P, Kang S, Lin MH, Chen X, Chen F, Guo M, Chen L, Ma CM.
    Med Dosim; 2014 Jul 15; 39(4):330-6. PubMed ID: 25087084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.